Press Releases

• Formation Bio: First Class of Entrepreneurs in Residence to Drive Pipeline Growth and Strategic Partnerships More
• Insmed: Positive Topline Results From Phase 2b Study of Treprostinil Palmitil Inhalation Powder (TPIP) as Once-Daily Therapy in Patients With Pulmonary Arterial Hypertension More
• Medicovestor and Sanyou Biopharmaceuticals: Forge Strategic Partnership to Develop First-in-Class Chemoimmunotherapy Antibody-Drug Conjugates More
• Merck: U.S. FDA Approves Merck’s ENFLONSIA (clesrovimab-cfor) for Prevention of Respiratory Syncytial Virus (RSV) Lower Respiratory Tract Disease in Infants Born During or Entering Their First RSV Season More More More* More*
• Outlook Therapeutics: SMC Recommendation of LYTENAVA (bevacizumab gamma) for the Treatment of Wet AMD More
• Paige and Breast International Group (BIG): Strategic Partnership to Advance AI-Driven Breast Cancer Research and Patient Care More

Financial News

• MindMed: New Employee Inducement Grants More
• No Drug Price Pledges by Pfizer, Others in Talks With US Government, Pfizer CEO Says More*
• Tevogen: Expands Headquarters Amid Growth of AI and Generics & Biosimilars Initiatives More More*
• The Damon Runyon Cancer Research Foundation: Launches New Seed Investment Program to Catalyze Biotech Funding More

Media/Misc Coverage

• FDA Adds Biomarker Limits to Stomach, Esophageal Cancer Labels for Merck’s Keytruda and BMS’ Opdivo More* More
  
• More on Axsome Plotting New Fibromyalgia Trial After FDA Refuses to Review Former Pfizer Candidate More
• More on Merck Saying Its Oral PCSK9 Inhibitor ‘Significantly’ Cut Cholesterol in Two Phase 3 Trials More* More* More More
  
• More on Weight-loss Newbie Metsera Saying Once-monthly Amylin Matches GLP-1 Efficacy More* More* More More
• Subscribe to LifeSci Startup for Updates on US Startups More
• ‘Time to Listen’: Pfizer Debuts Video Series About Life With Sickle Cell Disease More

Companies

Career Center

• Feature: The Future of Hiring: How Fractional Talent is Reshaping the Workplace More
• ICYMI: Beyond Cautious Optimism: Why a Hybrid Talent Model is the Future for Life Sciences & Healthcare More

• Accelerating Drug Discovery Using the Next Generation of Humanized Immune System (HIS) Mice June 11
• BIO Convention Receptions and Nearby Events June 12-19
• DIA 2025 Global Annual Meeting June 15-19
• Seoul Bio Forum June 16
  
• BIO International Convention June 16-19
• RESI Boston (Get $200 off with code BIG4BIO200) June 16
  
• RESI Boston Virtual June 17-18
• The Art of Fundraising June 24

NYC Sponsors